The life science market includes pharmaceuticals, medical devices, biotechnology, diagnostics, laboratory equipment, and research services, all of which contribute to advancing scientific knowledge ...
Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...
Curie.Bio, the biotech accelerator and investment firm started by Alexis Borisy and Zach Weinberg, has raised another $340 million to invest in startups. Borisy and Weinberg’s firm was created ...
critics warned that price controls would reduce companies' incentives to invest in medical research. And that's exactly what has happened. So far, biotech firms have pulled the plug on at least 40 ...
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...
While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...
Biotech companies are a subsector of healthcare stocks that primarily focus on developing new drugs and treatments for medical conditions, diseases and viruses. The stock value and growth ...
Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...
LONG BEACH — A player on the Cabrillo High School boys frosh-soph soccer team died Friday evening following an on-field medical emergency during a home game against Long Beach Poly. Also see ...
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...